TENIPOSIDE IN SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A PHASE-II TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP

被引：0
|
作者：
MUSS, HB
BUNDY, BN
YAZIGI, R
YORDAN, E
机构：
[1] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,WINSTON SALEM,NC 27103
[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,GYNECOL ONCOL GRP,BUFFALO,NY 14263
[3] UNIV TEXAS,HLTH SCI CTR,SW MED SCH,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,DALLAS,TX 75235
[4] RUSH PRESBYTERIAN ST LUKES MED CTR,GYNECOL ONCOL SECT,CHICAGO,IL 60612
来源：
CANCER TREATMENT REPORTS | 1987年 / 71卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：873 / 874
页数：2
相关论文
共 50 条
  • [31] PHASE-II TRIAL OF ETOPOSIDE IN THE MANAGEMENT OF ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE VULVA AND CARCINOMA OF THE VAGINA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SLAYTON, RE
    BLESSING, JA
    BEECHAM, J
    DISAIA, PJ
    CANCER TREATMENT REPORTS, 1987, 71 (09): : 869 - 870
  • [32] TENIPOSIDE (VM-26) IN PATIENTS WITH ADVANCED ENDOMETRIAL CARCINOMA - A PHASE-II TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP
    MUSS, HB
    BUNDY, BN
    ADCOCK, L
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (01): : 36 - 37
  • [33] Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix - A gynecologic oncology group study
    Garcia, Agustin A.
    Blessing, John A.
    Vaccarello, Luis
    Roman, Lynda D.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (04): : 428 - 431
  • [34] A phase II trial of pyrazoloacridine (PZA) in squamous carcinoma of the cervix - A Gynecologic Oncology Group study
    Plaxe, SC
    Blessing, JA
    Lucci, JA
    Hurteau, JA
    INVESTIGATIONAL NEW DRUGS, 2001, 19 (01) : 77 - 80
  • [35] Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: A phase II trial of the gynecologic oncology group
    Mannel, RS
    Blessing, JA
    Boike, G
    GYNECOLOGIC ONCOLOGY, 2000, 79 (01) : 64 - 66
  • [36] Phase II trial of bevacizumab in the treatment of recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
    Monk, B. J.
    Sill, M. W.
    Burger, R. A.
    Gray, H. J.
    Buekers, T. E.
    Roman, L. D.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S21 - S22
  • [37] A Phase II Trial of Pyrazoloacridine (PZA) in Squamous Carcinoma of the Cervix – A Gynecologic Oncology Group Study
    Steven C. Plaxe
    John A. Blessing
    Joseph A. Lucci
    Jean A. Hurteau
    Investigational New Drugs, 2001, 19 : 77 - 80
  • [38] Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group
    Muggia, FM
    Blessing, JA
    McGehee, R
    Monk, BJ
    GYNECOLOGIC ONCOLOGY, 2004, 94 (02) : 483 - 487
  • [39] MITOXANTRONE FOR CARCINOMA OF THE ENDOMETRIUM - A PHASE-II TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP
    MUSS, HB
    BUNDY, BN
    DISAIA, PJ
    EHRLICH, CE
    CANCER TREATMENT REPORTS, 1987, 71 (02): : 217 - 218
  • [40] PHASE-II STUDY OF VINBLASTINE IN PREVIOUSLY TREATED SQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SUTTON, GP
    BLESSING, JA
    BARNES, W
    BALL, H
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (06): : 470 - 471
12345